Ads
related to: Abbvie- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- AbbVie News Center
Search results
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 24 hours agoAbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
3 Dividend Stocks to Double Up on Right Now | The Motley Fool
The Motley Fool· 3 hours agoSeveral stocks that pay fantastic dividends are in that category. Here are three dividend stocks to...
Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?
Zacks via Yahoo Finance· 16 hours agoInvestors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 6 days agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc
GuruFocus.com via Yahoo Finance· 2 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and...
AbbVie share maintains hold, reiterates price target on Humira sales By Investing.com
Investing.com· 6 days agoOn Friday, Deutsche Bank reiterated its Hold rating on shares ofAbbVie (NYSE:ABBV), maintaining a...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately ...
AbbVie finalizes Landos Biopharma acquisition By Investing.com
Investing.com· 7 days agoThis drug is currently in Phase 2 clinical trials and is being studied as a potential treatment for...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare ...
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Motley Fool via Yahoo Finance· 4 days agoThere are magnificent stocks to buy in other industries, such as healthcare, which may provide...
Ad
related to: Abbvie